Abolis preview
Abolis favicon

Abolis Review

April 2026

$10M
Revenue
63
Employees
26%
Growth
Estimated Revenue
$10M
Total Funding
$40M
Total Employees
63
Employee Growth
26%
Industry
Biotech
Location
Evry
About

Accelerate your product innovation with microbial biotechnology solutions

Global Rank
N/A

What is Abolis's Revenue?

Abolis's estimated revenue is $10M.

What does Abolis do?

Accelerate your product innovation with microbial biotechnology solutions

CompanyRevenueEmployeesGrowthFunding
Dermavant SciencesDermavant Sciences
$99.4M45839.9%N/A
Metrum Research GroupMetrum Research Group
$20.6M13322.5%N/A
Clovis OncologyClovis Oncology
$156.1M146-69.8%$145M
ArcherDXArcherDX
$3.5M45-24.5%$150M
InscriptaInscripta
$1.6M210.0%$459.5M
CerapedicsCerapedics
$67.3M31015.4%$180.7M
Stone Clinical LaboratoriesStone Clinical Laboratories
$8.5M55-2.2%N/A
Apellis PharmaceuticalsApellis Pharmaceuticals
$256.3M1,0258.9%$168.5M
CreoSalusCreoSalus
$2.8M18-31.8%N/A
MSBiotecMSBiotec
$9.1M59-9.4%N/A
📊Analytics & Marketing1
☁️Cloud & Hosting1
🎯CSS Frameworks2
🎨Frontend Frameworks1
🔒Security1
🔧Web Standards2
Tracking & Analytics3
G
Google Analytics
G
Google APIs
G
Google Static

Technology detection powered by advanced web analysis

Powered byTechlist.ai